Training for FDA Medical Device Regulation, Recall, Quality and compliance


		Thursday - 3rd October 2013 02:00 PM IST \| 09:30 AM BST

Wednesday - 4th September 2013
02:00 PM EDT | 11:00 AM PDT

Friday - 13th September 2013
02:00 PM EDT | 11:00 AM PDT

Friday - 20th September 2013
02:00 PM EDT | 11:00 AM PDT

Thursday - 26th September 2013
01:00 PM EDT | 10:00 AM PDT

Thursday - 3rd October 2013
02:00 PM EDT | 11:00 AM PDT


		European and Canadian Experience Providing Insights into DEVELOPING BIOSIMILAR OR SUBSEQUENT ENTRY BIOLOGICS The importance & impact of the EU RMP& US REMS to risk-benefit assessments The current status of biosimilar biologics : Part 1: An international perspective The current status of biosimilar biologics : Part 2: Practical considerations in international development through European lessons learned


		Enuropean and Canadian Experience Providing Insights into DEVELOPING BIOSIMILAR OR SUBSEQUENT ENTRY BIOLOGICS The importance & impact of the EU RMP& US REMS to risk-benefit assessments The current status of biosimilar biologics : Part 1: An international perspective The current status of biosimilar biologics : Part 2: Practical considerations in international development through European lessons learned

Content Disclaimer:
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility
for the content of such links and websites.